CBIO - Catalyst Biosciences, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 587.72M
Enterprise Value 3-8.76M
Trailing P/E N/A
Forward P/E 1-1.73
PEG Ratio (5 yr expected) 10.07
Price/Sales (ttm)
Price/Book (mrq)0.94
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 60.18

Trading Information

Stock Price History

Beta (3Y Monthly) 2.55
52-Week Change 3-32.62%
S&P500 52-Week Change 31.11%
52 Week High 311.44
52 Week Low 36.20
50-Day Moving Average 38.05
200-Day Moving Average 38.36

Share Statistics

Avg Vol (3 month) 3198.89k
Avg Vol (10 day) 367.48k
Shares Outstanding 512.02M
Float 7.07M
% Held by Insiders 17.05%
% Held by Institutions 172.91%
Shares Short (Jul 31, 2019) 4439.86k
Short Ratio (Jul 31, 2019) 41.54
Short % of Float (Jul 31, 2019) 43.73%
Short % of Shares Outstanding (Jul 31, 2019) 43.66%
Shares Short (prior month Jun 28, 2019) 4927.25k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Aug 19, 2015
Ex-Dividend Date 4Aug 20, 2015
Last Split Factor (new per old) 215/1
Last Split Date 3Feb 13, 2017

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-26.01%
Return on Equity (ttm)-41.20%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-21.47M
EBITDA -49.87M
Net Income Avi to Common (ttm)-47.39M
Diluted EPS (ttm)-3.96
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)93.94M
Total Cash Per Share (mrq)7.82
Total Debt (mrq)2.03M
Total Debt/Equity (mrq)2.18
Current Ratio (mrq)15.83
Book Value Per Share (mrq)7.75

Cash Flow Statement

Operating Cash Flow (ttm)-42.46M
Levered Free Cash Flow (ttm)-26.16M